Softhread Announces Successful Completion of a Pilot with the MDEpiNet Coordinating Center at Weill Cornell Medicine

Demonstrating integration of the Chios™ platform with the High-Performance Integrated Virtual Environment, a distributed computing environment used for healthcare and biological research

We are pleased to announce the results of a successful collaboration between MDEpinet-HIVE and Softhread Inc. on a demonstration pilot to highlight the technical feasibility of integrating the Chios™ blockchain platform with the High-performance Integrated Virtual Environment (HIVE), which was conducted in partnership with HIVE system owners. The ecosystem has been built using High-performance Integrated Virtual Environment (HIVE) as provided by DNAHIVE and Blockchain data provenance and smart contract-driven permissioning system as provided by Softhread. The pilot was completed and demoed to the 2021 Temporomandibular Joint Coordinated Registry Network to showcase the first implementation of a patient-driven data registry ecosystem for Temporomandibular Joint Disorders.

“We are thrilled to be part of the MDEpiNet technology vision plan and to work with Softhread technology team on such foundational set of projects that will have a major impact on the way data-driven healthcare is conducted in the future. There is simply no other technology alternative to conducting complex analytics with such a sensitive dataset,” said DNAHIVE’s Chief Scientist Dr. Vahan Simonyan.

“We are extremely pleased to have demonstrated several of the core capabilities of our Chios™ platform during this pilot, such as pre-built, privacy-preserving smart contracts, advanced access control overlays, support for the publish/subscribe messaging pattern, and integration with off-chain, confidentiality-preserving machine learning models,” said Dr. Yelena Yesha, Co-Founder, and Chairwoman of Softhread.

This project is only the first step in highlighting the broader opportunities in leveraging and deploying the capabilities of our technology solutions that would address major pain points in the healthcare and life-sciences industries, as well as become the foundation for Precision Medicine regulatory and compliance efforts.

HIVE is a distributed computing environment used for healthcare technology and biological research. MDEpiNet-HIVE is a technology that provides a secure healthcare biomedical data archival ecosystem. MDEpiNet-HIVE maintains a standardization and harmonization framework, high-performance analytics, and an integrator platform. In addition to the initial HIVE applications to next-generation sequencing, the current universe of HIVE projects covers tailor-made applications involving dimensionality analysis, federated and integrated data mapping, modeling and simulations that apply to basic research, biostatistics, epidemiology, clinical studies, post-market evaluation, manufacturing consistency, environmental metagenomics, outbreak detection, etc.

SourceSofthread
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy

Exit mobile version